Our #WeekendRead π€
@emcdda's latest analysis of the drug situation in Europe
#EuropeanDrugReport2023 https://n.respublicae.eu/EMCDDA/status/1669661591896203264
<div class="rsshub-quote">
EU drugs agency:βπ’Just published: our analysis of the latest data on the drug situation and responses to it
πEuropean Drug Report 2023: Trends and Developments
This year, in a new digital-first and modular format:
https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
#EuropeanDrugReport2023 https://t.co/Hk050WNHml
</div>
π¦π: https://n.respublicae.eu/EUHomeAffairs/status/1675400914813812736
#WeekendRead #EuropeanDrugReport2023
π New mandate for the EU Drugs Agency.
@emcdda will have a stronger capacity for analysis and monitoring, and a faster and more efficient early warning system.
π½οΈ Commissioner @YlvaJohansson ~ #EuropeanDrugReport2023
π¦π: https://n.respublicae.eu/EUHomeAffairs/status/1673695956682829825
RTβYlva Johansson
European Drug Report 2023
Follow our launch live tomorrow π
https://audiovisual.ec.europa.eu/en/ebs/1/20230616
Start time 13h00 CET 16 June
With Director Alexis GOOSDEEL
<div class="rsshub-quote">
EU drugs agency:βComing soon! The European Drug Report 2023 will be launched in Brussels on 16 June. Find out more about the latest trends & developments on drugs in Europe. This year, the report is presented in a new digital-first format!
https://www.emcdda.europa.eu/news/2023/coming-soon-european-drug-report-2023-be-released-16-june_en
#EuropeanDrugReport2023 https://t.co/3WWZSGN852
</div>
π¦π: https://n.respublicae.eu/YlvaJohansson/status/1669412209133248514
RTβEU drugs agency
The #EuropeanDrugReport2023 will be launched today in Brussels at 12.00 (Lisbon time) / 13.00 (Brussels time).
Follow the press conference with Commissioner @YlvaJohansson and EMCDDA Director Alexis Goosdeel live: https://audiovisual.ec.europa.eu/en/ebs/live/1
@EUHomeAffairs @EU_Commission https://t.co/63DCqz5J0e
π¦π: https://n.respublicae.eu/EMCDDA/status/1669631146454286338
RTβEU drugs agency
π’Just published: our analysis of the latest data on the drug situation and responses to it
πEuropean Drug Report 2023: Trends and Developments
This year, in a new digital-first and modular format:
https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
#EuropeanDrugReport2023 https://t.co/Hk050WNHml
π¦π: https://n.respublicae.eu/EMCDDA/status/1669661591896203264
π’Greater diversity in drug supply and use creates new challenges for Europe π’
Read our news release on the launch of the #EuropeanDrugReport2023. Available in 25 languages:
https://www.emcdda.europa.eu/news/2023/european-drug-report-2023-highlights_en https://t.co/Q5jet35Ovb
π¦π: https://n.respublicae.eu/EMCDDA/status/1669676818020855810
RTβEU Home Affairs
βοΈ Drugs don't only damage people's health: they also damage our society. We must coordinate our response.
The #EuropeanDrugReport2023 was launched today in Brussels π§πͺ
Commissioner @YlvaJohansson & @emcdda Director Alexis Goosdeel. Details π
π¦π: https://n.respublicae.eu/EUHomeAffairs/status/1669703483660828676
Consult the Statistical Bulletin 2023, containing the source data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the #EuropeanDrugReport2023
https://www.emcdda.europa.eu/data/stats2023_en https://t.co/9eB985spDU
π¦π: https://n.respublicae.eu/EMCDDA/status/1669711483800780800
Watch our Director Alexis Goosdeel presenting the highlights of the #EuropeanDrugReport2023 https://youtu.be/cjSAYJdEGgw
π¦π: https://n.respublicae.eu/EMCDDA/status/1669720911853879297
Europe's drug situation continues to evolve, creating challenges for health and social responses.
Read about responding to these more diverse and complex needs in the #EuropeanDrugReport2023: https://www.emcdda.europa.eu/publications/european-drug-report/2023_en https://t.co/MtU77RnBcL
π¦π: https://n.respublicae.eu/EMCDDA/status/1670718282150625281
While supervised drug consumption rooms have become a more accepted harm reduction response, establishing them remains problematic in some countries. In 2022, 9 EU countries & Norway had operational facilities.
Read more in the #EuropeanDrugReport2023: https://www.emcdda.europa.eu/publications/european-drug-report/2023/harm-reduction_en https://t.co/6iIKhg7NF9
π¦π: https://n.respublicae.eu/EMCDDA/status/1670779037629706242
The scope of cannabis policies in Europe is gradually widening, now covering illicit cannabis control, regulation of cannabis for medical and other uses.
Read about new challenges for policy and practice in the #EuropeanDrugReport2023
https://www.emcdda.europa.eu/publications/european-drug-report/2023_en https://t.co/vb1t3JQpEK
π¦π: https://n.respublicae.eu/EMCDDA/status/1671080676911636480
Explore the prevalence of #cannabis use in Europe dashboard of the #EuropeanDrugReport2023 by recall period, age and country and get an overview of European and national trends: https://www.emcdda.europa.eu/publications/european-drug-report/2023/cannabis_en https://t.co/08T7Sth2Ql
π¦π: https://n.respublicae.eu/EMCDDA/status/1671140938817630209
#Cannabis #EuropeanDrugReport2023
Alongside #cocaine, consumption of synthetic stimulants is associated with risks to both physical and mental health.
Read about record cocaine seizures and growing concerns about synthetic stimulant use in the #EuropeanDrugReport2023
https://www.emcdda.europa.eu/publications/european-drug-report/2023_en https://t.co/hfptQPEzVg
π¦π: https://n.respublicae.eu/EMCDDA/status/1671443063149936640
#cocaine #EuropeanDrugReport2023
In 2021, EU Member States reported 68 000 seizures of cocaine, amounting to a historically high 303 tonnes (up from 211 tonnes in 2020).
Read more about the #cocaine market in Europe in the #EuropeanDrugReport2023:https://www.emcdda.europa.eu/publications/european-drug-report/2023/cocaine_en https://t.co/RqnF3vFcKF
π¦π: https://n.respublicae.eu/EMCDDA/status/1671503315773935617
#cocaine #EuropeanDrugReport2023
Drug availability remains high across all substance types and the scale and complexity of illicit drug production within Europe continue to grow.
Read about greater diversity in drug availability and use in the #EuropeanDrugReport2023 https://www.emcdda.europa.eu/publications/european-drug-report/2023_en https://t.co/ERjAxelpOr
π¦π: https://n.respublicae.eu/EMCDDA/status/1671805463401316353
Indexed trends show that the quantities of all drugs seized in the EU increased between 2011 and 2021. The largest increases: cocaine (+416 %), herbal cannabis (+260 %), methamphetamine (+135 %), heroin (+126 %), MDMA (+123 %).
#EuropeanDrugReport2023: https://www.emcdda.europa.eu/publications/european-drug-report/2023/drug-supply-production-and-precursors_en https://t.co/EtL9Ln2DBu
π¦π: https://n.respublicae.eu/EMCDDA/status/1671866064332890112
Heroin remains Europeβs most commonly used illicit opioid, but there is growing concern about synthetic #opioids.
Read more about complex opioid-related challenges in the #EuropeanDrugReport2023
https://www.emcdda.europa.eu/publications/european-drug-report/2023_en https://t.co/WK6kQhRVJz
π¦π: https://n.respublicae.eu/EMCDDA/status/1672167900432441346
#opioids #EuropeanDrugReport2023
Opioid use was reported as the main reason for entering specialised #treatment by 71 000 clients in 2021. Heroin was the primary drug for 74 % of the 16 000 first-time entrants who reported an opioid as their main problem drug.
#EuropeanDrugReport2023: https://www.emcdda.europa.eu/publications/european-drug-report/2023/heroin-and-other-opioids_en https://t.co/NCkhJmpJMh
π¦π: https://n.respublicae.eu/EMCDDA/status/1672228555139194882
#treatment #EuropeanDrugReport2023
One week to go until the launch of our #EuropeanDrugReport2023 on 16 June.
Find out more about the latest trends and developments on drugs in Europe. This year, the report is presented in a new digital-first format!
https://www.emcdda.europa.eu/news/2023/coming-soon-european-drug-report-2023-be-released-16-june_en
π¦π: https://n.respublicae.eu/EMCDDA/status/1667171108385071106